Inhibition of the jun N-terminal protein kinase pathway by SHIP-1, a lipid phosphatase that interacts with the adaptor molecule Dok-3

被引:54
作者
Robson, JD
Davidson, D
Veillette, A
机构
[1] Clin Res Inst Montreal, Mol Oncol Lab, Montreal, PQ H2W 1R7, Canada
[2] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada
[3] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3G 1Y6, Canada
[4] McGill Univ, Dept Med, Montreal, PQ H3G 1Y6, Canada
[5] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada
关键词
D O I
10.1128/MCB.24.6.2332-2343.2004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dok-3 is a Dok-related adaptor expressed in B cells and macrophages. Previously, we reported that Dok-3 is an inhibitor of B-cell activation in A20 B cells and that it associates with SHIP-1, a 5' inositol-specific lipid phosphatase, as well as Csk a negative regulator of Src kinases. Here, we demonstrate that Dok-3 suppresses B-cell activation by way of its interaction with SHIP-1, rather than Csk. Our biochemical analyses showed that the Dok-3-SHIP-1 complex acts by selectively inhibiting the B-cell receptor (BCR)-evoked activation of the Jun N-terminal protein kinase (JNK) cascade without affecting overall protein tyrosine phosphorylation or activation of previously described SHIP-1 targets like Btk and Akt/PKB. Studies of B cells derived from SHIP-1-deficient mice showed that BCR-triggered activation of JNK is enhanced in the absence of SHIP-1, implying that the Dok-3-SHIP-1 complex (or a related mechanism) is a physiological negative regulator of the JNK cascade in normal B cells. Together, these data elucidate the mechanism by which Dok-3 inhibits B-cell activation. Furthermore, they provide evidence that SHIP-1 can be a negative regulator of JNK signaling in B cells.
引用
收藏
页码:2332 / 2343
页数:12
相关论文
共 46 条
[1]   ENHANCEMENT OF T-CELL RESPONSIVENESS BY THE LYMPHOCYTE-SPECIFIC TYROSINE PROTEIN-KINASE P56LCK [J].
ABRAHAM, N ;
MICELI, MC ;
PARNES, JR ;
VEILLETTE, A .
NATURE, 1991, 350 (6313) :62-66
[2]   The inositol phosphatase SHIP inhibits Akt/PKB activation in B cells [J].
Aman, MJ ;
Lamkin, TD ;
Okada, H ;
Kurosaki, T ;
Ravichandran, KS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (51) :33922-33928
[3]   B cell development: signal transduction by antigen receptors and their surrogates [J].
Benschop, RJ ;
Cambier, JC .
CURRENT OPINION IN IMMUNOLOGY, 1999, 11 (02) :143-151
[4]   SHIP modulates immune receptor responses by regulating membrane association of Btk [J].
Bolland, S ;
Pearse, RN ;
Kurosaki, T ;
Ravetch, JV .
IMMUNITY, 1998, 8 (04) :509-516
[5]   Differential regulation of B cell development, activation, and death by the Src homology 2 domain-containing 5′ inositol phosphatase (SHIP) [J].
Brauweiler, A ;
Tamir, I ;
Dal Porto, J ;
Benschop, RJ ;
Helgason, CD ;
Humphries, RK ;
Freed, JH ;
Cambier, JC .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (09) :1545-1554
[6]  
Brauweiler AM, 2000, IMMUNOL REV, V176, P69
[7]  
CAMBIER JC, 1994, ANNU REV IMMUNOL, V12, P457, DOI 10.1146/annurev.immunol.12.1.457
[8]  
CAMBIER JC, 1995, J IMMUNOL, V155, P3281
[9]   NEGATIVE REGULATION OF T-CELL RECEPTOR SIGNALING BY TYROSINE PROTEIN-KINASE P50(CSK) [J].
CHOW, LML ;
FOURNEL, M ;
DAVIDSON, D ;
VEILLETTE, A .
NATURE, 1993, 365 (6442) :156-160
[10]  
Cong F, 1999, MOL CELL BIOL, V19, P8314